Bimekizumab Remission and High Disease Control Over 4 years in Patients with Psoriasis Achieving Complete Skin Clearance at Week 16: Results from Four Phase 3 Trials. J of Skin. 2026;10(2):s758. doi:10.25251/0bnq3318